Enhancement of the IFN-β-induced host signature informs repurposed drugs for COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative agent for the outbreak of coronavirus disease 2019 (COVID-19). This global pandemic is now calling for efforts to develop more effective COVID-19 therapies. Here we use a host-directed approach, which focuses on cellular res...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chen-Tsung, Chao, Tai-Ling, Kao, Han-Chieh, Pang, Yu-Hao, Lee, Wen-Hau, Hsieh, Chiao-Hui, Chang, Sui-Yuan, Huang, Hsuan-Cheng, Juan, Hsueh-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709728/
https://www.ncbi.nlm.nih.gov/pubmed/33289002
http://dx.doi.org/10.1016/j.heliyon.2020.e05646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709728/
https://www.ncbi.nlm.nih.gov/pubmed/33289002
http://dx.doi.org/10.1016/j.heliyon.2020.e05646

Ejemplares similares